4//SEC Filing
Mullins Kevin Michael 4
Accession 0000950170-23-059447
CIK 0001845257other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:30 PM ET
Size
5.1 KB
Accession
0000950170-23-059447
Insider Transaction Report
Form 4
Mullins Kevin Michael
Chief Development Officer
Transactions
- Sale
Common Stock
2023-11-03$6.13/sh−80,977$496,389→ 4,836,306 total
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
LifeStance Health Group, Inc.
CIK 0001845257
Entity typeother
Related Parties
1- filerCIK 0001864233
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:30 PM ET
- Size
- 5.1 KB